NexgenRx Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NEGXF research report →
Price Chart
About the company
NexgenRx, Inc. engages in the provision of administrative services only (ASO) (Self-Funded) drug, dental and extended health benefit plans supported by technology. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits.
- CEO
- Ronald C. Loucks
- IPO
- 2017
- Employees
- 20
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on NEGXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $31.29M
- Div Yield
- 3.28%
Latest fiscal year · YoY change
- Revenue
- $17.46M+6.0%
- Gross Profit
- $13.25M+0.9%
- Op Income
- $1.78M
- Net Income
- $1.29M+109.7%
- EPS
- $0.01+150.0%
- OCF Growth
- -87.3%
- FCF Growth
- -118.0%
- 52W High
- $0.48
- 52W Low
- $0.04
- 50D MA
- $0.44
- 200D MA
- $0.33
- Beta
- 0.43
- RSI (14)
- 56
- Avg Volume
- 786
No earnings-call transcripts are available for NEGXF yet.
- Free Float
- 63.0%
- Shares Outstanding
- 71.12M
- Float Shares
- 44.81M
Our NEGXF coverage
Recent articles, reports, and earnings notes.
No research on NEGXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NEGXF report →NexgenRx Announces Solid Q1 2026 Results with Continued Increasing Revenue, Net Income and EBITDA Growth
accessnewswire.com · May 21
NexgenRx Announces Declaration of Divdend
accessnewswire.com · Apr 17
NexgenRx Announces 2025 Year End Results with Continued Increasing Net Income, EBITDA And Revenue Growth
accessnewswire.com · Mar 31
NexgenRx Announces Declaration of Divdends
accessnewswire.com · Dec 10
NexgenRx Announces Declaration of Dividends
accessnewswire.com · Dec 10
NexgenRx Announces Significant Third Quarter Revenue and EBITDA Growth
accessnewswire.com · Nov 20
NexgenRx Announces Declaration of Dividend
accessnewswire.com · Aug 15
NexgenRx Announces Second Quarter Results with Significant Revenue Growth and Positive EBITDA
accessnewswire.com · Aug 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.